The Point: Sinovac executive addresses questions over safety & efficacy
CGTN, 28 Jan 2021
For more:
https://www.cgtn.com/video
As China races to vaccinate its people amid the biggest holiday of the year, how are vaccine companies addressing questions over safety and efficacy? CGTN talked to a representative from one of China's biggest vaccine companies.
Guest: Helen Yang, senior director of International Business Development of Sinovac Biotech, which produces CoronaVac, one of the Chinese vaccines being used across China and abroad.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://www.cgtn.com/video
As China races to vaccinate its people amid the biggest holiday of the year, how are vaccine companies addressing questions over safety and efficacy? CGTN talked to a representative from one of China's biggest vaccine companies.
Guest: Helen Yang, senior director of International Business Development of Sinovac Biotech, which produces CoronaVac, one of the Chinese vaccines being used across China and abroad.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
